Parties d'ouvrages collectifs (1)
  1. 1. Lorent, S., & De Backer, D. (2009). Patient safety and infusion technology. In J. Chiche, R. Moreno, C. Putensen, & A. Rhodes (Eds.), Patient Safety and Quality of Care in Intensive Care Medicine (pp. 323-335). Berlin: Medizinisch Wissenchaftliche Verlagsgesellschaft.(Patient safety in the ICU).
    2.   Articles dans des revues avec comité de lecture (12)
  2. 1. Hoornaert, C., Pochet, S., & Lorent, S. (2022). Development and Delphi validation of a Best Possible Medication History form. European journal of hospital pharmacy. doi:10.1136/ejhpharm-2021-003095
  3. 2. Taccone, F., Gardette, M., Creteur, J., Brasseur, A., Lorent, S., & Grimaldi, D. (2021). Hemoadsorption to treat severe iatrogenic intoxication with Patent Blue: a case report. Journal of Medical Case Reports, 15(1), 63. doi:10.1186/s13256-020-02657-6
  4. 3. Hoornaert, C., Pochet, S., Vervacke, A., & Lorent, S. (2019). Étude pilote: évaluation de l’élargissement du rôle des assistants pharmaceutico-techniques et infirmiers dans le déploiement de l’anamnèse médicamenteuse dans le service des urgences: Assessment of an expanded role of pharmacy technicians and nurses in the deployment of medication histories recording in emergency department: pilot study. Journal de pharmacie clinique, 38(1), 27-36.
  5. 4. Vosters, O., Jaadar, Y., Vidts, L. A., Demols, A., Lorent, S., Lievin, V., & Demoulin, M. (2018). Implementation of a new health information technology for the management of cancer chemotherapies. European journal of hospital pharmacy, 25(5), 281-285. doi:10.1136/ejhpharm-2016-001135
  6. 5. Vervacke, A., Lorent, S., & Motte, S. (2014). Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium. International Journal of Clinical Pharmacy, 36(5), 1007-1013. doi:10.1007/s11096-014-9988-8
  7. 6. Donadello, K., Cristallini, S., Taccone, F., Lorent, S., Vincent, J. L., De Backer, D., & Jacobs, F. (2013). Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature. International journal of antimicrobial agents, 42(6), 580-583. doi:10.1016/j.ijantimicag.2013.07.015
  8. 7. Hites, M., Taccone, F., Wolff, F., Cotton, F., Beumier, M., De Backer, D., Roisin, S., Lorent, S., Surin, R., Seyler, L., Vincent, J. L., & Jacobs, F. (2013). Case-control study of drug monitoring of β-lactams in obese critically ILL patients. Antimicrobial agents and chemotherapy, 57(2), 708-715. doi:10.1128/AAC.01083-12
  9. 8. He, X., Su, F., Velissaris, D., Salgado, D., de Souza Barros, D., Lorent, S., Taccone, F., Vincent, J. L., & De Backer, D. (2012). Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shock. Critical care medicine, 40(10), 2833-2840. doi:10.1097/CCM.0b013e31825b88ba
  10. 9. Naeije, G., Lorent, S., Vincent, J. L., & Legros, B. (2011). Continuous epileptiform discharges in patients treated with cefepime or meropenem. Archives of neurology, 68(10), 1303-1307. doi:10.1001/archneurol.2011.204
  11. 10. Lorent, S., Lievin, V., Ballarin, A., Van Gossum, A., & Preiser, J.-C. (2011). L'administration des médicaments par sonde d'alimentation entérale. Réanimation, 20(4), 354-357. doi:10.1007/s13546-011-0286-3
  12. 11. Ahishakiye, D., Lorent, S., De Backer, D., Gottignies, P., & Vincent, J. L. (2009). Drotrecogin alfa (activated) for severe sepsis: Could we consider a shorter treatment period in patients with a favorable course? Journal of critical care, 24(4), 590-594. doi:10.1016/j.jcrc.2009.03.009
    13. << Précédent 1 2 3 Suivant >>